Momordica charantia is an herbal climber grown in tropical and subtropical regions, belonging to the Cucurbitaceae family. M. charantiacan be used as remedyagainst various diseases from ancient time. It has been used in various Asian traditional medicines for the treatment of cholera, bronchitis, anemia, blood diseases, ulcer, diarrhea, dysentery, gonorrhea rheumatism, gout, worms, colic, disease of liver and spleen, cancer and diabetes etc. The main constituents of M. charantia are triterpene, protein, steroid, alkaloid, inorganic, lipid, and phenolic compounds, which are responsible for biological and pharmacological activities including anti-diabetic, anti-cancerous and anti-tumorous, anti-microbial, anti-viral, anti-helmintic, antimalarial, anti-ulcerative and immunomodulatory. Combination of its Ayuervedic properties i.e. Gunna, Rasa and Virya (Dry, pungent, light, bitter and hot) makes it the real natures wonder. Hence the present study is planned to evaluate the biological characteristic like antioxident and antimicrobial properties of M. charantia. These activities will be sassessed by using different assay viz. total phenolics, total flavonols and scavenging assay for 1,1, diphenyl-2- picrylhydrazyl (DPPH). The antimicrobial activity will be evaluated by disc diffusion method.
| Published in | Advances in Bioscience and Bioengineering (Volume 9, Issue 1) |
| DOI | 10.11648/j.abb.20210901.12 |
| Page(s) | 8-12 |
| Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
| Copyright |
Copyright © The Author(s), 2024. Published by Science Publishing Group |
Momordica charantia Linn, General Description, Medicinal Properties
| [1] | GUPTA M., SHURMA S., GAUTAM A. K., BHADAURIA R. M. charantia: nature silent healer. Res Rev J Pharm Pharm Sci. 11 (1), 32, 2011. |
| [2] | FANG E. F., ZHANG C. Z. Y., WONG J. H., SHEN J. Y., Li C. H., Ng T. B. The MAP30 protein from bitter gourd (M. charantia) seeds promotes apoptosis in liver cancer cells in vitro and in vivo. J. Cancer Letters. 66, 2012. |
| [3] | ALAM M., UDDIN R., SUBHAN N., RAHMAN M. M., JAIN P., REZA HM. Beneficial Role of Bitter Melon Supplementation in Obesity and Related Complications in Metabolic Syndrome. J FOOD LIPIDS Journal ISSN: 1065-7258. 1.2015. |
| [4] | GROVER J. K., YADAV S. P. Pharmacological actions and potential uses of M. charantia: a review. J Ethnopharmacol. 123.2004. |
| [5] | PAUL A., RAYCHAUDHURI S. S. Medicinal Uses and Molecular Identification of Two M. charantia Varieties – a review. Electron. j. 6 (2), 43, 2010. |
| [6] | SHARMA S., TANDON S., SEMWAL B., SINGH K. M. charantia: A Comprehensive Review on Bitter Remedy. Br J Pharm Res. 1 (2), 42, 2011. |
| [7] | PANDAY DR., RAUNIARB G. P., PANDAY K. R. M. charantia (Karela); An Antidiabetic. World. J. Pharm. Pharm. Sci. 4 (1), 84, 2014. |
| [8] | ZHU Y., DONG Y., QIAN X., CUI F., GUO Q., ZHOU X., WANG Y., ZHANG Y., XIONG Z. Effect of Superfine Grinding on Antidiabetic Activity of Bitter Melon Powder. Int. J. Mol. Sci. 3, 2012. |
| [9] | ANJUM F., SHAHID M., BUKHARI S. A., ANWAR S., LATIF S. Study of Quality Characteristics and Efficacy of Extraction Solvent/ Technique on the Antioxidant Activity of Bitter Gourd Seed. J Food Process Technol. 4 (2), 2, 2013. |
| [10] | KUMAR D. S., SHARATHNATH K. V., YOGESWARAN P., HARANI A., SUDHAKAR K., SUDHA P., BANJI D. A Medicinal Potency of M. charantia. Int. J Pharm Sci Rev Res. 1 (2), 95, 2010. |
| [11] | HAMISSOU M., SIMTH A. C., J. R REC., TRIPLETT J. K. Antioxidative properties of bitter gourd (M. charantia) and zucchini (cucurbitapepo). Emir J Food Agric. 25 (9), 641, 2013 |
| [12] | ANILAKUMAR K. R., KUMAR G. P., ILAIYARAJA N (2015). Nutritional, pharmacological and medicinal properties of M. charantia. Int. J. Food Sci. Nutr. 4 (1), 75, 2015. |
| [13] | GIULIANI C., TANI C., BINI L. M. Micromorphology and anatomy of fruits and seeds of bitter melon (M. charantia, Cucurbitaceae). Published by Polish Botanical Society ActaSoc Bot Pol. 85 (1), 1, 2015. |
| [14] | Pornsuriya., Pramote., Pornsuriya., Pornthip., Numuen., C. Phenotypic diversity and classification of Thai bitter melon (M. charantia.) landraces from three provinces in central region of Thailand. Int J Environ. 7 (3), 849, 2011. |
| [15] | KIM H. Y., MOK S. Y., KWON S. H., LEE D. G., CHO E. J., LEE S. Phytochemical Constituents of Bitter Melon (M. charantia)."Nat. Prod. Sci. 19 (4), 286, 2013. |
| [16] | RAMALINGUM N., MAHOMOODALLY MF. The therapeutic Potential of Medicinal Foods. Hindawi Publishing Corpoation Advances in Pharmacological Sciences. 1-18, 2014 |
| [17] | POONAM T., PRAKASH G. P., KUMAR L. V. Interaction of M. Charantia With Metformin In Diabetic Rats. Am J Pharmacol Toxicol. 8 (3): 102, 2013 |
| [18] | AHMAD N., HASAN N., AHMAD Z., ZISHAN M., ZOHRAMEENA S. M. Charantia: For Traditional Uses and Pharmacological ActionsJ Drug Deliv Sci Technol. 6 (2), 40, 2016. |
| [19] | JOSEPH B., JINNI D. Antidiabetic effect of M. charantia (bitter melon) and its medicinal potency. Asian Pac J Trop Dis. 2013. |
| [20] | DAS DR., SACHAN A. K., IMTIYAZ M., SHUAIB M. M. charantia as a Potential Medicinal Herb: An Overview. J. Med. Plants. Stud. 3 (5), 23, 2015. |
| [21] | MOHAMMADY I., ELATTAR S., MOHAMMED S., EWAIS M. An Evaluation of Anti-Diabetic and Anti-Lipidemic Properties of M. charantia (Bitter Melon) Fruit Extract in Experimentally Induced Diabetes. Life Sci. 9 (2), 363, 2012. |
| [22] | HOSSAIN M. A., MOSTOFA M., DEBNATH D., ALAM A., YASMIN Z., MOITRY NF. Antihyperglycemic and Antihyperlipidemic of Karala (M. charantia) Fruits in Streptozotocin Induced Diabetic Rats. J Environ Sci. 5 (1), 29, 2012. |
| [23] | MOBARAKI A., MOGHADDAM T. N. Karela, a Plant with Many Properties. International Journal of Agriculture Innovations and Research. 3 (1), 2319, 2014. |
| [24] | TAN S. P., STATHOPOULOS C., PARKS S., ROACH P. An Optimised Aqueous Extract of Phenolic Compounds from Bitter Melon with High Antioxidant Capacity. Antioxidants. 3, 814, 2014. |
| [25] | K. J. R., N. P. V. Antioxidant Properties of Bitter Gourd (M. Charantia). International Journal of Advanced Engineering, (IJAEMS). 2 (10), 2454, 2016. |
| [26] | RAJAN S., PUSHPA Dr A. In vitro evaluation of enzymic antioxidants in the seed and leaf samples of Syzygiumcumini and M. charantia. Int J Sci Res. 5 (12), 476, 2015. |
| [27] | KENNY O., SMYTH T. J., HEWAGE C. M., BRUNTON NP. Antioxidant properties and quantitative UPLC-MS/MS analysis of phenolic compounds in dandelion (Taraxacumofficinale) root extracts. Free Radicals and Antioxidants. 4 (1), 2014. |
| [28] | OZUSAGLAM M. A., KARAKOCA K. Antimicrobial and antioxidant activities of M. charantia from Turkey. Afr. J. Biotechnol. 12 (13), 1548, 2013. |
| [29] | JAGESSAR R. C., MOHAMEDA A., GOMESB G. An evaluation of the Antibacterial and Antifungal activity of leaf extracts of M. Charantia against Candida albicans, Staphylococcus aureus and Escherichia coli. Nature and Science. 6 (1), 1545, 2008. |
| [30] | MAHMOOD A., RAJA G. K., MAHMOOD T., GULFRAZMUHAMMAD., KHANUMA. Isolation and characterization of antimicrobial activity conferring component (s) from seeds of bitter gourd (M. charantia). J Med Plant Res. 6 (4), 566, 2012. |
| [31] | JAYINI R. Cytotoxic Activity Of MomordicaCharantia Seed Extract. 1, 2012. |
| [32] | KAI H., AKAMATSU E., TORII E., KODAMA H., YUKIZAKI C., AKAGI I., INO H., SAKAKIBARA Y., SUIKO M., YAMAMOTO I., OKAYAMA A., MORISHITA K., KATAOKA H., MATSUNO K. Identification of a Bioactive Compound against Adult T-cell Leukaemia from Bitter Gourd Seeds. Plants. 3, 18, 2014. |
| [33] | SHOBHA C. R., VISHWANATH P., SUMA M. N., PRASHANT A., RANGASWAMY C., GOWDAPPA BH. In vitro anti-cancer activity of ethanolic extract of M. charantia on cervical and breast cancer cell lines. Int. j. res. health allied sci. 4 (4), 210, 2015. |
| [34] | DE S., CHAKRABORTY J., DAS S. Oral Consumption of Bitter Gourd and Tomato Prevents Lipid Peroxidation in Liver Associated with DMBA Induced Skin Carcinogenesis in Mice. Asian Pac J Cancer Prev. 1, 205, 2000. |
| [35] | SUMANTH M., CHOWDARY G. N. Antimutagenic activity of aqueous extract of M. charantia. Int. J. Biotechnol. Mol. Biol. Res. 1 (4), 42, 2010. |
| [36] | CHIAMPANICHAYAKUL S., KATAOKA K., ARIMOCHI H., THUMVIJIT S., KUWAHARA T., NAKAYAMA H., INITKETKUMNUEN UV., OHNISHI Y. Inhibitory effects of bitter melon (Momordicacharantia Linn.) on bacterial mutagenesis and aberrant crypt focus formationintheratcolon. J Med Invest. 48: 88, 2001. |
APA Style
Zermina Khalid, Syeda Mona Hassan, Shahzad Sharif Mughal, Syed Khurram Hassan, Huma Hassan. (2021). A Review on Biological Attributes of Momordica charantia. Advances in Bioscience and Bioengineering, 9(1), 8-12. https://doi.org/10.11648/j.abb.20210901.12
ACS Style
Zermina Khalid; Syeda Mona Hassan; Shahzad Sharif Mughal; Syed Khurram Hassan; Huma Hassan. A Review on Biological Attributes of Momordica charantia. Adv. BioSci. Bioeng. 2021, 9(1), 8-12. doi: 10.11648/j.abb.20210901.12
AMA Style
Zermina Khalid, Syeda Mona Hassan, Shahzad Sharif Mughal, Syed Khurram Hassan, Huma Hassan. A Review on Biological Attributes of Momordica charantia. Adv BioSci Bioeng. 2021;9(1):8-12. doi: 10.11648/j.abb.20210901.12
Share This Article
Twitter
Linked In
Facebook
Copy
Download@article{10.11648/j.abb.20210901.12,
author = {Zermina Khalid and Syeda Mona Hassan and Shahzad Sharif Mughal and Syed Khurram Hassan and Huma Hassan},
title = {A Review on Biological Attributes of Momordica charantia},
journal = {Advances in Bioscience and Bioengineering},
volume = {9},
number = {1},
pages = {8-12},
doi = {10.11648/j.abb.20210901.12},
url = {https://doi.org/10.11648/j.abb.20210901.12},
eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.abb.20210901.12},
abstract = {Momordica charantia is an herbal climber grown in tropical and subtropical regions, belonging to the Cucurbitaceae family. M. charantiacan be used as remedyagainst various diseases from ancient time. It has been used in various Asian traditional medicines for the treatment of cholera, bronchitis, anemia, blood diseases, ulcer, diarrhea, dysentery, gonorrhea rheumatism, gout, worms, colic, disease of liver and spleen, cancer and diabetes etc. The main constituents of M. charantia are triterpene, protein, steroid, alkaloid, inorganic, lipid, and phenolic compounds, which are responsible for biological and pharmacological activities including anti-diabetic, anti-cancerous and anti-tumorous, anti-microbial, anti-viral, anti-helmintic, antimalarial, anti-ulcerative and immunomodulatory. Combination of its Ayuervedic properties i.e. Gunna, Rasa and Virya (Dry, pungent, light, bitter and hot) makes it the real natures wonder. Hence the present study is planned to evaluate the biological characteristic like antioxident and antimicrobial properties of M. charantia. These activities will be sassessed by using different assay viz. total phenolics, total flavonols and scavenging assay for 1,1, diphenyl-2- picrylhydrazyl (DPPH). The antimicrobial activity will be evaluated by disc diffusion method.},
year = {2021}
}
TY - JOUR T1 - A Review on Biological Attributes of Momordica charantia AU - Zermina Khalid AU - Syeda Mona Hassan AU - Shahzad Sharif Mughal AU - Syed Khurram Hassan AU - Huma Hassan Y1 - 2021/03/26 PY - 2021 N1 - https://doi.org/10.11648/j.abb.20210901.12 DO - 10.11648/j.abb.20210901.12 T2 - Advances in Bioscience and Bioengineering JF - Advances in Bioscience and Bioengineering JO - Advances in Bioscience and Bioengineering SP - 8 EP - 12 PB - Science Publishing Group SN - 2330-4162 UR - https://doi.org/10.11648/j.abb.20210901.12 AB - Momordica charantia is an herbal climber grown in tropical and subtropical regions, belonging to the Cucurbitaceae family. M. charantiacan be used as remedyagainst various diseases from ancient time. It has been used in various Asian traditional medicines for the treatment of cholera, bronchitis, anemia, blood diseases, ulcer, diarrhea, dysentery, gonorrhea rheumatism, gout, worms, colic, disease of liver and spleen, cancer and diabetes etc. The main constituents of M. charantia are triterpene, protein, steroid, alkaloid, inorganic, lipid, and phenolic compounds, which are responsible for biological and pharmacological activities including anti-diabetic, anti-cancerous and anti-tumorous, anti-microbial, anti-viral, anti-helmintic, antimalarial, anti-ulcerative and immunomodulatory. Combination of its Ayuervedic properties i.e. Gunna, Rasa and Virya (Dry, pungent, light, bitter and hot) makes it the real natures wonder. Hence the present study is planned to evaluate the biological characteristic like antioxident and antimicrobial properties of M. charantia. These activities will be sassessed by using different assay viz. total phenolics, total flavonols and scavenging assay for 1,1, diphenyl-2- picrylhydrazyl (DPPH). The antimicrobial activity will be evaluated by disc diffusion method. VL - 9 IS - 1 ER -
Email: